News

Mumbai, India-based Lupin earned Food and Drug Administration approval for its generic cough syrup, according to Drug Store News. Here are three things to know. 1. The syrup is a combination of ...
Lupin has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, a U.S. biopharmaceutical company focused exclusively on Women's Health. Lupin's U.S. Commercial Women's ...
Lupin’s shares rose 2.8% in afternoon trading after the company received a key U.S. Food and Drug Administration (FDA) approval. On Wednesday, Lupin received USFDA approval for its Abbreviated New ...
Lupin has entered into a license and supply agreement with SteinCares, a specialty healthcare company in Latin America, for commercialization of Lupin’s biosimilar ranibizumab across Latin America ...
Forbes contributors publish independent expert analyses and insights. Making wealth creation easy, accessible and transparent. Lupin Pharmaceuticals has recalled two batches of its Tydemy birth ...
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Lupin Manufacturing Solutions has announced that Empagliflozin API, manufactured at its Vizag facility, has received CADIFA ...